Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1, kappa
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1, kappa
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1, kappa
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1
CV30
Severe acute respiratory syndrome coronavirus (SARS-CoV), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1
CR3022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1
VHH-72-Fc
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1
B38
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1
H4
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgM
B38
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, WB
Human
Monoclonal
IgG1, kappa
2D2